Consult us 24/7

Request an

Header Form

GDP Certification in Japan

Implementation, Consulting, Auditing & Certification at one place . We focus on taking your business to new heights.

GDP Certification in Japan
GDP Certification in Japan

Request a Call Back

Request Form

GDP Certification In Japan helps pharmaceutical wholesalers, manufacturers with distribution responsibilities, and logistics providers demonstrate controlled handling of medicinal products from receipt through delivery. Without suitable controls, a temperature excursion during Japan’s hot and humid season, a delayed shipment after a typhoon, or disruption caused by an earthquake can make it difficult to demonstrate that product integrity was protected. B2BCERT prepares the defined distribution scope for independent third-party assessment. The relevant MHLW framework is the “Guideline for Good Distribution Practice of Medicinal Products”, issued on December 28, 2018; MHLW explains that it was developed with reference to PIC/S GDP and intended to encourage industry use rather than create a government-issued GDP certificate.

Why Pharmaceutical Businesses in Japan Consider GDP Certification

GDP Certification In Japan needs to be considered alongside the Japanese pharmaceutical licensing and quality framework. For a wholesale distributor, the PMD Act requires a wholesale sales licence for each business office, granted by the prefectural governor, and Article 35 sets requirements for management of that office. For your operation, this means the number and location of licensed business offices can affect the sites that need to be mapped when defining a distribution and certification scope. For a Marketing Authorization Holder, GDP arrangements also need to fit its existing GDP responsibilities. The GQP framework requires an appropriate quality-management organization and assigns defined duties to the quality assurance responsible person, including oversight of quality-management activities. Japan-specific distribution conditions should then be assessed at site and route level. A Tokyo or Yokohama operation receiving imported medicines through major port infrastructure may have different receiving and environmental-control risks from a regional warehouse in Osaka.

A Nagoya facility serving central Japan may manage extended domestic road movements, while a distributor sending products from Honshu to Hokkaido or Kyushu needs to consider longer transit exposure, seasonal temperature conditions and disruption to transport routes. Typhoon and earthquake scenarios should also be reflected in documented business-continuity and pharmaceutical protection arrangements. The MHLW GDP guideline is therefore best treated as a practical reference for strengthening distribution controls, while statutory licensing and GQP requirements remain separate Japanese obligations.

GDP Certification in Japan for Pharmaceutical Manufacturers

GDP Implementation in Japan for a pharmaceutical manufacturer should start where released products enter storage, dispatch and transportation. A manufacturer may already have Japanese GMP controls, but those controls do not remove the need to examine how released medicines are protected while moving through warehouses, carriers, wholesalers and other distribution arrangements. PMDA conducts GMP inspections of manufacturing sites to assess manufacturing and quality controls, so GMP and GDP should be managed as connected but distinct areas. B2BCERT can structure the distribution work around the manufacturer’s actual Japanese supply chain:

  • Scope and responsibility mapping: Identify the products, Japanese sites, distribution activities, contracted services and personnel responsible for each control.
  • Distribution risk assessment: Examine temperature exposure, route duration, security, delays and emergency conditions affecting pharmaceutical shipments.
  • Quality-system alignment: Connect distribution procedures with applicable GQP, GMP, deviation, change-control and document-management processes.
  • Warehouse assessment: Review temperature mapping, monitoring, calibration, segregation, stock status, access controls and environmental conditions.
  • Transport qualification: Examine carrier capability, packaging, monitoring devices, route risks and controls for temperature-sensitive products.

What Happens After a GDP Certification Audit in Japan?

GDP Audit in Japan should test the controls within the defined certification scope and trace them through actual distribution records. B2BCERT prepares the business for independent assessment, but the certification decision belongs to the independent certification organization selected for the engagement. Japan has a particularly relevant example for shared pharmaceutical distribution. On October 6, 2022, MHLW issued a notification concerning shared dispatch centres operated by multiple wholesale distributors. It allows electronic distinction of medicines belonging to different wholesalers where specified conditions are satisfied, including an appropriately validated computerized system. The notification states that the distinction must remain possible across distribution activities, including returns, recalls and disposal.

An audit-ready operation should be able to produce evidence covering:

  • Temperature mapping and monitoring records for controlled storage areas.
  • Calibration and maintenance records for relevant monitoring equipment.
  • Traceability records for receipt, storage, dispatch and delivery activities.
  • Qualification evidence for suppliers, customers and contracted logistics providers.
  • Deviation records showing investigation and appropriate disposition of temperature excursions.
  • Controls for pharmaceutical security, segregation and restricted warehouse access.

A useful pre-assessment exercise is to select one pharmaceutical shipment and follow its evidence from receipt to delivery. This can reveal missing records, unclear responsibilities or control failures that are not apparent when individual procedures are reviewed separately.

Does GDP Certification Cost Vary by Business Size in Japan?

GDP Cost in Japan depends on the certification scope, number of sites, product conditions and complexity of the distribution network. A particularly important Japanese scoping factor is that the PMD Act provides for a wholesale sales licence for each business office, with the relevant prefectural governor granting the licence. Consequently, a wholesaler operating several licensed business offices cannot assume that reviewing one warehouse automatically represents every Japanese location.

B2BCERT can establish the consulting scope by examining:

  • Number of licensed wholesale business offices and other sites proposed for assessment.
  • Products handled and their specified storage or transportation conditions.
  • Warehouse configuration, operating arrangements and distribution volume.
  • Transportation providers, third-party logistics facilities and outsourced activities.
  • Existing procedures, records and evidence available for the proposed scope.

The cost should therefore be established after defining the actual Japanese distribution scope. The wholesale licence and GDP assessment should also remain commercially distinct: the former is a statutory pharmaceutical licensing requirement, while the latter is an independent conformity-assessment activity based on the selected scheme and scope.

GDP Certification Maintenance and Renewal in Japan

GDP Renewal In Japan should be planned around changes that can alter distribution risk. A business extending its network from Osaka to Hokkaido or Kyushu, adding a temperature-sensitive product, changing a transport provider or opening another storage location should reassess the affected controls rather than simply carry forward an old procedure. For a long-distance Japan route, the review can include transit duration, seasonal temperature exposure, monitoring arrangements, carrier capability and contingency measures. An operation exposed to typhoon disruption or earthquake risk should also establish defined responsibilities for protecting stock, evaluating affected facilities and deciding whether distribution can safely resume. Renewal preparation should then focus on the evidence required by the selected certification scheme and certification body’s surveillance process. Relevant records may include significant changes, previous assessment findings, open corrective actions, equipment qualification and outsourced-service performance. This gives the business a controlled basis for demonstrating that its certification scope remains suitable for its current operation.

Expert GDP Consulting Services for Japan Businesses

GDP Consultants In Japan from B2BCERT support pharmaceutical wholesalers, manufacturers with distribution responsibilities, import-related businesses and logistics providers preparing for independent GDP assessment. For a Japanese operation using multiple licensed wholesale business offices, outsourced warehousing or a shared dispatch centre, we align the preparation with the applicable distribution scope, PMD Act responsibilities, stock identification and service-provider controls. B2BCERT can support gap assessment, GDP documentation, warehouse and transportation controls, implementation guidance, evidence preparation and audit readiness based on the selected certification scope. B2BCERT does not issue GDP certification or make the independent conformity decision. The certification is assessed by an independent certification body; B2BCERT provides consulting and preparation support. Final regulatory interpretation should be reviewed by an appropriately qualified Japanese pharmaceutical quality professional where MAH/GQP responsibilities, wholesale licensing, temperature-sensitive medicines or shared distribution facilities are involved.

Get Free Consultation

Consultation Form

Have any Questions?

Mail us Today!
contact@b2bcert.com

Frequently asked questions

Who Requires GDP Certification in Japan?

Any company involved in the distribution of pharmaceutical products, including manufacturers, wholesalers, distributors, and pharmacies, may require GDP Certification. Additionally, companies engaged in the international trade of pharmaceuticals may seek GDP Certification to comply with various regional and international regulations.

What are the Key Elements Evaluated During a GDP Audit in Japan?

During a GDP audit in Japan, several key elements are assessed to determine compliance. These include proper handling and storage practices, temperature control, transportation procedures, record-keeping, and product security measures.

How Long Does It Take to Obtain GDP Certification in Japan?

The time required to obtain GDP Certification in Japan can vary depending on the company’s current level of compliance and the complexity of its distribution process. Generally, the preparation process, including internal audits and corrective actions, may take several months. Once the company is ready, the actual certification process can take a few weeks to complete.

What is the Purpose of a GDP Certification Audit in Japan?

A GDP Certification Audit in Japan aims to assess and ensure that pharmaceutical products are distributed safely, efficiently, and in compliance with regulatory guidelines. This process guarantees product quality and minimizes risks associated with distribution, safeguarding the supply chain.

How Often Should GDP Audits in Japan be Conducted?

The frequency of GDP audits varies based on factors like the type of product, the risk involved, and regulatory requirements. Generally, audits are conducted at least once every two years, but high-risk products may require more frequent audits.

What is the Role of GDP Consultants in Japan?

GDP Consultants in Japan are specialized professionals who provide guidance and support to pharmaceutical companies in adhering to Good Distribution Practices (GDP). Their primary role is to ensure that companies comply with regulatory requirements, maintain product quality, and implement efficient distribution processes throughout the pharmaceutical supply chain.

Are GDP Consultants Familiar with International GDP Regulations in Japan?

Yes, GDP Consultants are well-versed in international GDP regulations and standards. They assist companies engaged in international trade to navigate the complex requirements of different countries and regions. Ensuring compliance with international GDP regulations is crucial for smooth cross-border distribution.

Get Free Consultation
Consultation Form